These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7249797

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM, Lamport PA, Reeves DS, Bywater MJ, Holt HA, Wise R, Andrews J, Hall MJ.
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
    Eickhoff TC, Ehret J.
    Antimicrob Agents Chemother; 1981 Mar; 19(3):435-42. PubMed ID: 6264845
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
    Aldridge KE, Schiro DD, Sanders CV.
    Eur J Clin Microbiol; 1987 Oct; 6(5):564-9. PubMed ID: 3436316
    [Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
    Jones RN, Erwin ME.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
    [Abstract] [Full Text] [Related]

  • 9. In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.
    Shannon K, King A, Warren C, Phillips I.
    Antimicrob Agents Chemother; 1980 Aug; 18(2):292-8. PubMed ID: 6969574
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides.
    Seibert G, Limbert M, Winkler I, Dick T.
    Infection; 1983 Aug; 11(5):275-9. PubMed ID: 6315595
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R, Waldvogel FA.
    Clin Ther; 1980 Aug; 3(Spec Issue):89-97. PubMed ID: 6446401
    [Abstract] [Full Text] [Related]

  • 14. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L, Le Van Thoi J, Soussy CJ, Duval J.
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T, Jalanko E, Scheinin L, Renkonen OV.
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [Abstract] [Full Text] [Related]

  • 16. [Activity of new beta-lactam antibiotics].
    Cullmann W, Stieglitz M.
    Fortschr Med; 1982 May 20; 100(19):888-92. PubMed ID: 6807788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
    Beskid G, Fallat V, Lipschitz ER, McGarry DH, Cleeland R, Chan K, Keith DD, Unowsky J.
    Antimicrob Agents Chemother; 1989 Jul 20; 33(7):1072-7. PubMed ID: 2782857
    [Abstract] [Full Text] [Related]

  • 19. Cefpiramide: comparative in-vitro activity and beta-lactamase stability.
    Barry AL, Jones RN, Thornsberry C, Fuchs PC, Ayers LW, Gavan TL, Gerlach EH, Sommers HM.
    J Antimicrob Chemother; 1985 Sep 20; 16(3):315-25. PubMed ID: 3877041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.